CelerNetwork, a compatibility protocol that enables seamless asset transfers across numerous L1 networks, has announced the successful integration of Injective, a decentralized exchange and trading platform. This integration will introduce unique assets from a broad variety of L1 and L2 networks into the ecosystem of Injective. It makes it possible for a number of assets, such as Astar Network, a prominent parachain on the Polkadot network, to be included in Injective for the very first time.
CelerNetwork Partnership Enhances dApps Capabilities on Injective
Through the completion of this integration, Injective is going to keep expanding the scope of its capabilities in terms of interoperability. In fact, of all businesses in this sector, Injective will have one of the biggest numbers of linkages between chains. With the ability to host cross-chain assets on Cosmos, Ethereum, and Solana, Injective has quickly established itself as one of the most interoperable networks currently available.
Trending Now: Bybit Makes Identity Verification Compulsory for All Services
Celer’s integration with Injective will allow developers to include efficient usage of liquidity, and shared states. It also includes logically consistent application logic into their decentralized applications (dApps). Celer is the driving force behind cBridge, a non-custodial and decentralized asset bridge. It supports more than 150 different tokens and has handled over $13 billion in trade. cBridge now has the capability of supporting the bridging of resources such as Astar, Injective, and Polkadot as a result of the latest integration.
Injective Strengthens its Position as Principal Gateway with Celer Integration
The combination of Celer and Injective brings significant value to the ecosystem that handles Injective materials. With the ability to expand its access into more networks, like Astar and Polkadot, Injective will boost its cross-chain capabilities to new heights. Decentralized applications (dApps) built on Injective may now handle additional assets that could not be accessed before. This will strengthen Injective’s position as the principal gateway for assets to access the larger IBC market.
Injective will now provide one of the industry’s biggest numbers of cross-chain connections, and with the support of Celer. It will continue to expand its capabilities in terms of interoperability. The integration of Celer and Injective is a significant step towards a more interconnected blockchain ecosystem. It can support the seamless transfer of assets across multiple networks. The combination of these two technologies opens up a new world of possibilities for developers and users alike. It will enable them to take advantage of the benefits of cross-chain connectivity in a seamless and efficient manner.